A.I.Sure Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.70 M
- Paid Up Capital ₹ 2.67 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.05 M
- Revenue Growth 40.87%
- Profit Growth 8.91%
- Ebitda 6.57%
- Net Worth -124.43%
- Total Assets 92.22%
About A.I.Sure Pharmaceutical
A.I.Sure Pharmaceutical Private Limited (APPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 April 2018 (Six years and nine months 11 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.70 M and a paid-up capital of Rs 2.67 M.
The company currently has active open charges totaling ₹4.05 M.
Shanawaz Kazi, Mohammed Sheikh, and Sachin Malawade serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93090PN2018PTC176233
-
Company No.
176233
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Apr 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does A.I.Sure Pharmaceutical Private Limited offer?
A.I.Sure Pharmaceutical Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules.
Who are the key members and board of directors at A.I.Sure Pharmaceutical?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shanawaz Kazi | Director | 01-Apr-2022 | Current |
Mohammed Sheikh | Director | 24-Apr-2018 | Current |
Sachin Malawade | Director | 18-May-2021 | Current |
Financial Performance of A.I.Sure Pharmaceutical.
A.I.Sure Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.87% increase. The company also saw a slight improvement in profitability, with a 8.91% increase in profit. The company's net worth observed a substantial decline by a decrease of 124.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of A.I.Sure Pharmaceutical?
In 2022, A.I.Sure Pharmaceutical had a promoter holding of 56.25% and a public holding of 43.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.05 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.41 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
08 Jun 2021 | Axis Bank Limited | ₹4.05 M | Open |
How Many Employees Work at A.I.Sure Pharmaceutical?
A.I.Sure Pharmaceutical has a workforce of 18 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A.I.Sure Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A.I.Sure Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.